Avanos Medical (AVNS) Competitors $12.32 -0.17 (-1.32%) Closing price 05/23/2025 03:59 PM EasternExtended Trading$12.29 -0.02 (-0.19%) As of 05/23/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVNS vs. LIVN, ENOV, NVCR, LMAT, SSII, CNMD, WRBY, EYE, TNDM, and LQDAShould you be buying Avanos Medical stock or one of its competitors? The main competitors of Avanos Medical include LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), LeMaitre Vascular (LMAT), SS Innovations International (SSII), CONMED (CNMD), Warby Parker (WRBY), National Vision (EYE), Tandem Diabetes Care (TNDM), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry. Avanos Medical vs. LivaNova Enovis NovoCure LeMaitre Vascular SS Innovations International CONMED Warby Parker National Vision Tandem Diabetes Care Liquidia Avanos Medical (NYSE:AVNS) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk, profitability and community ranking. Which has better earnings and valuation, AVNS or LIVN? LivaNova has higher revenue and earnings than Avanos Medical. LivaNova is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvanos Medical$689.20M0.83-$61.80M-$8.37-1.47LivaNova$1.28B1.79$17.55M-$4.09-10.24 Is AVNS or LIVN more profitable? Avanos Medical has a net margin of 2.30% compared to LivaNova's net margin of 1.91%. LivaNova's return on equity of 13.81% beat Avanos Medical's return on equity.Company Net Margins Return on Equity Return on Assets Avanos Medical2.30% 4.70% 3.46% LivaNova 1.91%13.81%7.07% Do institutionals and insiders believe in AVNS or LIVN? 95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 2.6% of Avanos Medical shares are owned by company insiders. Comparatively, 0.3% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community favor AVNS or LIVN? LivaNova received 322 more outperform votes than Avanos Medical when rated by MarketBeat users. Likewise, 69.80% of users gave LivaNova an outperform vote while only 55.77% of users gave Avanos Medical an outperform vote. CompanyUnderperformOutperformAvanos MedicalOutperform Votes8755.77% Underperform Votes6944.23% LivaNovaOutperform Votes40969.80% Underperform Votes17730.20% Does the media refer more to AVNS or LIVN? In the previous week, LivaNova had 10 more articles in the media than Avanos Medical. MarketBeat recorded 15 mentions for LivaNova and 5 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.71 beat LivaNova's score of 1.38 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive LivaNova 10 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, AVNS or LIVN? Avanos Medical has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Do analysts recommend AVNS or LIVN? LivaNova has a consensus price target of $59.29, indicating a potential upside of 41.56%. Given LivaNova's stronger consensus rating and higher probable upside, analysts clearly believe LivaNova is more favorable than Avanos Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryLivaNova beats Avanos Medical on 15 of the 19 factors compared between the two stocks. Get Avanos Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVNS vs. The Competition Export to ExcelMetricAvanos MedicalSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$569.50M$9.40B$5.34B$19.28BDividend YieldN/A1.28%5.27%3.85%P/E Ratio36.2220.6226.9634.43Price / Sales0.8363.69398.8134.86Price / Cash7.6419.6738.3217.51Price / Book0.465.056.774.69Net Income-$61.80M$284.66M$3.24B$1.02B7 Day Performance-6.11%-1.85%0.26%-2.38%1 Month Performance-1.48%-3.46%6.07%4.34%1 Year Performance-38.33%-21.24%18.46%4.87% Avanos Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVNSAvanos Medical2.6636 of 5 stars$12.32-1.3%N/A-38.0%$569.50M$689.20M36.224,040Positive NewsLIVNLivaNova3.7793 of 5 stars$43.97-1.0%$59.17+34.6%-29.5%$2.40B$1.28B104.692,900Positive NewsAnalyst UpgradeENOVEnovis3.1127 of 5 stars$35.45-1.7%$58.00+63.6%-36.8%$2.03B$2.15B-16.196,800Positive NewsGap DownNVCRNovoCure3.5944 of 5 stars$17.96+0.4%$32.83+82.8%-16.9%$2.00B$621.71M-12.831,320Positive NewsGap DownLMATLeMaitre Vascular2.6037 of 5 stars$85.96+1.4%$98.14+14.2%+2.3%$1.94B$226.26M46.97490Insider TradeSSIISS Innovations InternationalN/A$9.74-1.0%N/AN/A$1.89B$20.65M0.004CNMDCONMED4.4972 of 5 stars$60.18-0.2%$62.20+3.4%-24.2%$1.86B$1.32B14.194,100Positive NewsDividend AnnouncementWRBYWarby Parker3.085 of 5 stars$17.59-0.7%$22.00+25.1%+18.0%$1.84B$795.09M-65.153,030Trending NewsAnalyst ForecastAnalyst RevisionGap DownEYENational Vision2.771 of 5 stars$19.22flat$17.75-7.6%+25.7%$1.52B$1.85B-96.1014,000Positive NewsGap DownTNDMTandem Diabetes Care4.4153 of 5 stars$22.73-1.5%$39.81+75.2%-58.3%$1.51B$982.95M-11.782,600Positive NewsAnalyst ForecastGap DownLQDALiquidia3.3229 of 5 stars$17.03-9.8%$25.56+50.1%+19.5%$1.46B$14.14M-10.4550News CoverageAnalyst ForecastHigh Trading Volume Related Companies and Tools Related Companies LivaNova Competitors Enovis Competitors NovoCure Competitors LeMaitre Vascular Competitors SS Innovations International Competitors CONMED Competitors Warby Parker Competitors National Vision Competitors Tandem Diabetes Care Competitors Liquidia Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AVNS) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! Save 85% on Weiss Crypto Investor!President Trump just made his first big crypto move … Announcing the creation of a national strategic reser...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
